Department of Urology, University of Texas Southwestern, Dallas, Texas.
Department of Urology, Mayo Clinic, Rochester, Minnesota.
J Endourol. 2019 Oct;33(10):829-834. doi: 10.1089/end.2019.0263. Epub 2019 Sep 27.
Tissue retraction during minimally invasive surgery has been achieved to date with patient positioning or additional instrumentation. The Levita™ Magnetic Surgical System (San Mateo, CA), a novel, noninvasive, magnetic retraction device for minimally invasive surgery, has been used to facilitate reduced-port robotic prostatectomy using a multiport robotic platform. With the release of the da Vinci SP robotic system (Intuitive, Sunnyvale, CA), we now report a multi-institutional initial case series of magnet-assisted robotic prostatectomy using the single-port robotic platform. An IRB-approved, retrospective chart review was performed of all patients undergoing robot-assisted radical prostatectomy using the da Vinci SP surgical system and a single Levita magnetic retractor in treatment of prostatic adenocarcinoma at two institutions from November 2018 to January 2019. Preoperative, intraoperative, and postoperative data were collected for descriptive analysis. A total of 15 men, median age 62 years (range 57-71), with mean PSA 7.0 ± 2.3 underwent surgery. The robotic cannula and a single 12-mm assistant port were utilized in all cases, the latter for suction, suture passage, and clip placement; the magnetic retractor aided with posterior dissection, dorsal venous complex stitch placement, bladder neck dissection, and lymphadenectomy. No cases required conversion to a multiport robotic platform, laparoscopy, or open surgery, nor placement of additional assistant ports. No intraoperative or postoperative complications occurred. Average operative time was 224 ± 43 minutes and blood loss was 198 ± 115 mL. All patients were discharged home within 2 days of surgery. Robotic prostatectomy utilizing the da Vinci SP system is feasible, safe, and effective. Use of the magnetic retractor facilitates tissue exposure and improves procedure ergonomics, mimicking the conventional multiport technique. Further exploration of magnet utilization in robotic surgery and optimization of assistant port placement for true single-site surgery is warranted.
迄今为止,微创外科中的组织回缩是通过患者体位或额外的器械来实现的。Levita™ 磁性手术系统(加利福尼亚州圣马特奥)是一种新颖的、非侵入性的、用于微创外科的磁性牵引设备,已用于使用多端口机器人平台辅助减少端口机器人前列腺切除术。随着达芬奇 SP 机器人系统(Intuitive,加利福尼亚州森尼韦尔)的发布,我们现在报告了一项多机构的初始病例系列,使用单端口机器人平台进行磁辅助机器人前列腺切除术。对两家机构在 2018 年 11 月至 2019 年 1 月期间使用达芬奇 SP 手术系统和单个 Levita 磁性牵开器治疗前列腺腺癌的所有接受机器人辅助根治性前列腺切除术的患者进行了 IRB 批准的回顾性图表审查。收集了术前、术中、术后数据进行描述性分析。共有 15 名男性,中位年龄 62 岁(范围 57-71),平均 PSA 7.0±2.3,接受手术。所有病例均使用机器人套管和单个 12-mm 辅助端口,后者用于抽吸、缝线通过和夹放置;磁性牵开器辅助进行后解剖、背静脉复合体缝合放置、膀胱颈部解剖和淋巴结切除术。没有病例需要转换为多端口机器人平台、腹腔镜或开放性手术,也不需要放置额外的辅助端口。没有发生术中或术后并发症。平均手术时间为 224±43 分钟,失血量为 198±115mL。所有患者均在手术后 2 天内出院。使用达芬奇 SP 系统进行机器人前列腺切除术是可行、安全且有效的。使用磁性牵开器可促进组织暴露并改善手术操作的人体工程学,模拟传统的多端口技术。进一步探索机器人手术中磁体的应用以及优化真正的单部位手术的辅助端口放置是有必要的。